CLOSE ×

    Cell line references

    Tissue sub-type Cell line References Mice Models Rat Models
    Cancer Stem Cells (Human Tissue)
    Adenocarcinoma A549
    Adenocarcinoma H1975
    Brain BTSC83 Athymic nude mice
    Brain Glioblastoma
    Brain LA-N-5 Athymic nude mice
    Brain NGC-407-GFP nude
    Brain U87-SC
    Breast 2LMP (MDA-MB-231 subclone) NOD.SCID mice
    Breast BCM-2147 SCID/beige mice
    Breast BCM-2665 SCID/beige mice
    Breast BCM-3887 SCID/beige mice
    Breast BCM-4195 SCID/beige mice
    Breast MCF-7 (CSC-like) Athymic nude mice
    Breast MCF-7 (mammospheres) Athymic nude mice
    Breast SUM159 NOD.SCID mice
    Breast NMuMG-RFP NOD.SCID mice
    Breast E1KD-GFP NOD.SCID mice
    Breast (mammary) LTR-MycER DCIS NOD.SCID mice
    Colon Colon tumor tissue NOD.SCID mice
    Gastric GSC1 SCID/beige mice
    Glioma CD133 SCID/beige mice
    Glioma OCT4/SOX2 SCID/beige mice
    Lung A549 Athymic nude mice
    Lung H1299 Athymic nude mice
    Ovarian A2780-CR5 [ALDH(+) and ALDH(-)] Athymic nude mice
    Ovarian SKOV-3 (spherical cells) BALB/c nude mice
    Prostate DU-145 (spheroid cells) NOD.SCID mice
    Human Tissue
    Bladder KU-7 Athymic nude mice
    Bladder T24 NOD.SCID mice nude
    Bladder T24- Luc
    Bladder UM-UC1 Athymic nude mice
    Bladder UM-UC13 Athymic nude mice
    Bladder UM-UC3 Athymic nude mice
    Bladder RT4 NOD.SCID mice
    Bladder HT-1376 NOD.SCID mice
    Bladder 5637 NOD.SCID mice
    Bladder 5637-Luc
    H157 SCID/beige mice
    Bladder H1299 SCID/beige mice
    Brain A-172 Athymic nude mice
    Brain G55 Athymic nude mice nude
    Brain GL15 SCID mice
    Brain HTLA-230
    Brain SH-SY5Y nude
    Brain TB10 Athymic nude mice
    Brain U251 Athymic nude mice nude
    Brain U251 MG
    Brain U251-NG2 Athymic nude mice
    Brain U87 nude, RAG2 KO(SD)
    Brain U87ΔEGFR Athymic nude mice
    Brain U87MG nude
    Brain U87Fluc
    Brain U87MG.wt EGFR Athymic nude mice
    Brain U87-TARTK NOD.SCID mice
    Brain U138MG
    Brain U373 nude
    Brain SH-EP Athymic nude mice
    Brain WAC2 Athymic nude mice
    Brain D341 Med Athymic nude mice
    Brain D384 Med Athymic nude mice
    Brain D425 Med Athymic nude mice
    Brain (astrocytoma) U87 RAG2 KO(SD)
    Brain (diffuse intrinsic pontine glioma) TT150630
    Brain (diffuse intrinsic pontine glioma) TT150728
    Breast 231/LM2-4 nude
    Breast BT-474
    Breast BT-474C Athymic nude mice nude
    Breast BT474-EEI
    Breast BT-474-M1
    Breast BT-474/TR Athymic nude mice
    Breast HCC1569 Athymic nude mice
    Breast JIMT-1
    Breast KPL-4
    Breast MCF-7 nude
    Breast MCF-GFP Athymic nude mice
    Breast MCF-RSK4 Athymic nude mice
    Breast MCF/HER2-18 Athymic nude mice
    Breast MDA-MB-175
    Breast MDA-MB-231 nude
    Breast MDA-MB-231-mCherry Athymic nude mice
    Breast MDA-MB-231-Luc NOD.SCID mice
    Breast MDA-MB-361 Athymic nude mice
    Breast MDA-MB-435 Athymic nude mice
    Breast MDA-MB-453
    Breast MDA-MB-468
    Breast MEF-p95-HER2 Athymic nude mice
    Breast MT-1 nude
    Breast T47D
    Breast ZR-75-1 nude
    Breast BT549 Athymic nude mice
    Breast MIV-shSCR NOD.SCID mice
    Breast MIV-INHBA NOD.SCID mice
    Breast CACNA1H NOD.SCID mice
    Breast MCF-7eGFP Athymic nude mice
    Breast MCF-7FGFR1 Athymic nude mice
    Breast MCFDCIS Athymic nude mice
    Breast BT-474R2 Athymic nude mice
    Cervical HeLa Athymic nude mice nude
    Cervical Hep-2 (HeLa contaminant) BALB/c nude mice
    Cervical ME-180 nude
    Cervical SiHa nude
    Carcinoma HCC95 Athymic nude mice
    Carcinoma KYSE-180 Athymic nude mice
    Carcinoma CMV-luciferase
    Carcinoma Sk-HEP-1 (nano-Luc+)
    Colon BCS-TC2.2 Athymic nude mice
    Colon Colo201 Athymic nude mice
    Colon Colo205 nude
    Colon Colo320 Athymic nude mice
    Colon Colo320-CD9 Athymic nude mice
    Colon GEO
    Colon HCA-7 Athymic nude mice
    Colon HCT-15 Athymic nude mice
    Colon LoVo Athymic nude mice nude
    Colon LS174T Athymic nude mice
    Colon MV522
    Colon SW480 SCID mice
    Colon SW48 Athymic nude mice
    Colon LIM1215 Athymic nude mice
    Colorectal CX-1 Athymic nude mice
    Colorectal DLD-1 Athymic nude mice
    Colorectal HCT-116
    Colorectal HT-29 nude
    Colorectal SW620 Athymic nude mice
    Endometrial ECC-1 Athymic nude mice
    Esophageal FLO-1 Athymic nude mice
    Esophageal OE19
    Esophageal OE21 Athymic nude mice
    Esophageal OE33 Athymic nude mice
    Esophageal OE47 Athymic nude mice
    Fibrosarcoma HT1080
    Gastric MKN45 Athymic nude mice
    Gastric N87
    Gastric HS746T Athymic nude mice
    Gastric OE-19 SCID/beige mice
    Gastric JIMT-1 SCID/beige mice
    Gastric RN-87 SCID/beige mice
    Gastric ROE-19 SCID/beige mice
    Gastric SNU-216 SCID/beige mice
    Gastrointestinal GIST-T1 SCID/beige mice
    H157 SCID/beige mice
    H1299 SCID/beige mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) Cal-27 Athymic nude mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) CCL 23 (HeLa contaminant) Athymic nude mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) FaDu Athymic nude mice nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) HeLa-O3 Athymic nude mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) HNX-OE Athymic nude mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) SCC-1 Athymic nude mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) UM-SCC1 Athymic nude mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) UMSCC38 Athymic nude mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) WSUHN-31 Athymic nude mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#1 NOD.SCID mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#2 NOD.SCID mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#3 NOD.SCID mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#4 NOD.SCID mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#5 NOD.SCID mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#6 NOD.SCID mice
    Leukemia ARH-77 SCID mice
    Leukemia HEL9217 SCID mice
    Leukemia HL60 SCID mice
    Leukemia HPB-ALL nude
    Leukemia K562
    Leukemia KG-1 SCID mice
    Leukemia MV4-11 nude
    Leukemia TF1-α SCID mice
    Leukemia THP-1 SCID mice
    Leukemia ERY-1 Athymic nude mice
    Leukemia GFP‐labeled Reh PRPS1
    Leukemia NALM6 ALL
    Leukemia Reh ALL
    Leukemia (acute myeloid) RUVBL1/2 SCID/beige mice
    Leukemia (acute myeloid) AML SCID/beige mice
    Leukemia (acute myeloid) AML1-ETO Athymic nude mice
    Liver AKH10 SCID/beige mice
    Liver Hep3B Athymic nude mice nude
    Liver Hep-G2
    Liver HepT1 nude
    Liver HuCCT1 Athymic nude mice
    Liver HuH6 Athymic nude mice nude
    Liver Huh-7 SCID mice
    Liver KFJ6 SCID/beige mice
    Liver KFJ9 SCID/beige mice
    Liver KFJ10 SCID/beige mice
    Liver COA67 Athymic nude mice
    Lung adenocarcinoma H157 SCID/beige mice
    Lung adenocarcinoma H1299 SCID/beige mice
    Lung A549 nude
    Lung A549m Athymic nude mice
    Lung BEN SCID/beige mice
    Lung Calu6 nude
    Lung Colo-699 SCID/beige mice
    Lung H226B Athymic nude mice
    Lung H358 Athymic nude mice
    Lung KNS-62 SCID/beige mice
    Lung L2987
    Lung LX-1
    Lung NCI-H460 nude
    Lung NCI-H69
    Lung NCI-H82 Athymic nude mice
    Lung NCI-H841 SCID mice
    Lung NCI-N417 Athymic nude mice
    Lung PC-9/BRc1 Athymic nude mice
    Lung H292 Athymic nude mice
    Lung H865 Athymic nude mice
    Lung H2122 Athymic nude mice
    Lung TC1 Luc Athymic nude mice
    Lymphoma (non-Hodgkin's) DoHH2 SCID mice
    Lymphoma (non-Hodgkin's) Ramos SCID mice
    Lymphoma (non-Hodgkin's) WSU-DLCL2 SCID mice
    Lymphoma (non-Hodgkin's) Raji
    Lymphoma (non-Hodgkin's) L-428 Athymic nude mice
    Lymphoma CA46 SCID mice
    Lymphoma Granta SCID mice
    Lymphoma Karpas-299
    Lymphoma Raji
    Lymphoma L540cy SCID mice
    Lymphoma SP53 SCID mice
    Lymphoma Z138 SCID mice
    Lymphoma Human Lymphoma B (P493)
    Lymphoma Nalm6 SCID/beige mice
    Lymphoma REC-1 Athymic nude mice
    Lymphoma SU-DHL-2
    Melanoma 518A2
    Melanoma 537MEL
    Melanoma 607B SCID mice
    Melanoma A2058 SCID mice
    Melanoma A375 Athymic nude mice
    Melanoma A375M Athymic nude mice
    Melanoma DM6 nude
    Melanoma FM82 NOD.SCID mice
    Melanoma Ge SCID/beige mice
    Melanoma Mel-JUSO SCID mice
    Melanoma MelM9 SCID mice
    Melanoma NIH1286 Athymic nude mice
    Melanoma SIT1 SCID mice
    Melanoma SK-MEL23
    Melanoma SK-MEL23/155 NOD.SCID mice
    Melanoma UACC Athymic nude mice
    Melanoma VM
    Melanoma hCMEC/D3 NOD.SCID mice
    Melanoma SC-1800 NOD.SCID mice
    Melanoma H1 (or H1_DL2) NOD.SCID mice
    Melanoma H2 NOD.SCID mice
    Mesothelioma DEVy nude
    Mesothelioma shNT-Gpx4 iKO-TGL MSTO-211H NOD.SCID mice
    Mesothelioma hMerlin-Gpx4 iKO-TGL MSTO-211H NOD.SCID mice
    Mesothelioma shNT HCT116 Athymic nude mice
    Mesothelioma shLats1/2 HCT116 Athymic nude mice
    Multiple Myeloma ARP-1 SCID mice
    Multiple Myeloma KAS-6/1 SCID mice
    Multiple Myeloma L-363 SCID mice
    Multiple Myeloma LAGΛ-1 Athymic nude mice
    Multiple Myeloma MM.1S
    Multiple Myeloma MPC-11
    Multiple Myeloma NCI-H929 NOD.SCID mice
    Multiple Myeloma RPMI
    Multiple Myeloma U266 NOD.SCID mice
    Multiple Myeloma RUVBL1/2
    Multiple Myeloma NCI-H929 NOD.SCID mice
    Multiple Myeloma RPMI-8226 NOD.SCID mice
    Multiple Myeloma OPM-2 NOD.SCID mice
    Multiple Myeloma AMO-1 NOD.SCID mice
    Multiple Myeloma JJN3 NOD.SCID mice
    Multiple Myeloma NEK2‐OE KMS11
    Neuroblastoma COA3 NOD.SCID mice
    Neuroblastoma COA6 NOD.SCID mice
    Oral 686LN Athymic nude mice
    Oral KB (HeLa contaminant) Athymic nude mice nude
    Osteosarcoma OS-17 SCID mice
    Osteosarcoma 143B SCID mice
    Ovarian A2780 SCID mice
    Ovarian 1A9 Athymic nude mice
    Ovarian 1A9ptx10 Athymic nude mice
    Ovarian A2780
    Ovarian CAOV3 Athymic nude mice
    Ovarian CD228
    Ovarian HEY Athymic nude mice
    Ovarian MW387
    Ovarian NMP-1 Athymic nude mice
    Ovarian OVA-1 SCID mice
    Ovarian OVCAR-3
    Ovarian OVCAR4 Athymic nude mice
    Ovarian OVCAR8 SCID/beige mice
    Ovarian PA354
    Ovarian SKOV-3 nude
    Ovarian SKOV3-luc Athymic nude mice nude
    Ovarian fLuc+ SK-OV-3
    Pancreatic AsPC-1 Athymic nude mice nude
    Pancreatic BxPC-3 Athymic nude mice
    Pancreatic BxPC3/vector Athymic nude mice
    Pancreatic BxPC3/shSTAT3 Athymic nude mice
    Pancreatic Bx/shRON Athymic nude mice
    Pancreatic CFPAC-1 Athymic nude mice
    Pancreatic Colo357
    Pancreatic HPAC Athymic nude mice nude
    Pancreatic L3.6pl Athymic nude mice
    Pancreatic MIA-Luc Athymic nude mice
    Pancreatic MIA PaCa-2 Athymic nude mice
    Pancreatic PANC-1
    Pancreatic Panc185 Athymic nude mice
    Pancreatic Panc89 SCID mice
    Pancreatic Panc430 Athymic nude mice
    Pancreatic PL45 Athymic nude mice
    Pancreatic T3M4 Athymic nude mice
    Prostate CWR22
    Prostate DU-145
    Prostate LAPC4 Athymic nude mice
    Prostate LNCaP
    Prostate LuCap35
    Prostate MDA-PCa-2b
    Prostate PC-3
    Prostate PC-3M Athymic nude mice
    Prostate VCaP Athymic nude mice
    Prostate 22Rv1 Athymic nude mice
    Prostate C4-2 Athymic nude mice
    Prostate ARCaPM Athymic nude mice
    Prostate LNCaP-HSD17B2
    Renal 786O
    Renal ACHN NOD.SCID mice
    Renal Caki-1 Athymic nude mice
    Renal Caki-1 CLDN7-Luc
    Renal Caki-2 Athymic nude mice
    Renal SK-NEP-1 Athymic nude mice
    Renal MRKT Athymic nude mice
    Renal G401 Athymic nude mice
    Renal Primary (Immortalized) SCID/beige mice
    Renal SMMC-7721-luciferase
    Retinoblastoma Y79 Athymic nude mice
    Sarcoma SK-LMS-1 Athymic nude mice
    Skin (HPV16)BC-1-Ep/SL-LF
    Skin (benign) Shope papilloma Athymic nude mice
    Skin (Merkel Cell Carcinoma) MCPyV-positive MCC cell lines NOD.SCID mice
    A431
    Testicular NCCIT Athymic nude mice
    Thyroid CAL62 NOD.SCID mice
    Thyroid CAL62-splice cells NOD.SCID mice
    Thyroid H1299 SCID/beige mice
    Thyroid H157 SCID/beige mice
    Uveal melanoma M619 SCID mice
    Uveal melanoma MUM2B SCID mice
    Uveal melanoma OCM1a SCID mice
    Vulva A431
    Vulva SK-LMS-1 nude
    Colon LS411N Athymic nude mice
    Colon SW403 Athymic nude mice
    Pancreatic CFPAC-1 Athymic nude mice
    Lung H226 (NSCLC) Athymic nude mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) SCC1483 Athymic nude mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) SCC1 (cetuximab-resistant) Athymic nude mice
    Brain GS-11 SCID mice
    Lymphoma MUTU-1 SCID mice
    Brain T87 GSC nude
    Breast MDA-IBC3 SCID/beige mice
    Breast SUM149 SCID/beige mice
    Patient-Derived Tumors (Human Tissue)
    Brain (PDX) Athymic nude mice nude
    Brain U87MG (GBM PDX) Athymic nude mice
    Breast BMC-2147 SCID/beige mice
    Breast HBCX 1 Athymic nude mice
    Breast HBCX 6 Athymic nude mice
    Breast HBCX 7 Athymic nude mice
    Breast HBCX 9 Athymic nude mice
    Breast HBCX 12B Athymic nude mice
    Breast HBCX 17 Athymic nude mice
    Breast HBCx-3 BALB/c nude mice
    Breast HBCx-4A BALB/c nude mice
    Breast HBCx-8 BALB/c nude mice
    Breast HBCx-24 BALB/c nude mice
    Breast HBCx-30 BALB/c nude mice
    Breast PDX60 NMRI nude mice
    Breast PDX156 NMRI nude mice
    Breast MC1 SCID/beige mice
    Breast TNBC (MC1) NOD.SCID mice
    Breast BCM-2147 SCID/beige mice
    Breast BCM-4013 SCID/beige mice
    Breast BCM-4888 SCID/beige mice
    Breast BCM-4272 SCID/beige mice
    Breast BCM-3887 SCID/beige mice
    Breast SUM149 SCID/beige mice
    Breast HCI-001 NOD.SCID mice
    Breast HCI-010 NOD.SCID mice
    Breast HMEC SCID/beige mice
    Breast A73 SCID/beige mice
    Breast E0771 SCID/beige mice
    Breast E0771-ICBR SCID/beige mice
    Breast PyMT-M SCID/beige mice
    Breast PyMT-N SCID/beige mice
    Breast PyMT-M-ICBR SCID/beige mice
    Breast PDX-1079
    Breast PDX-9327
    Breast PDX-1173
    Breast SUM149PT NOD.SCID mice
    Breast HCC1428 NOD.SCID mice
    Breast MDAMB468 NOD.SCID mice
    Breast ZR751 NOD.SCID mice
    Breast PDX PT1-17 Athymic nude mice
    Breast MCF7 Athymic nude mice
    Breast HIM3 Athymic nude mice
    Carcinoma (Intrahepatic cholangiocarcinoma) PDX0044 (ICC PDX)
    Colorectal (BRAF mutant PDX) NMRI nude mice
    Colorectal (KRAS mutant PDX) NMRI nude mice
    Colorectal (PIK3CA mutant PDX) NMRI nude mice
    Colorectal (PTEN mutant PDX) NMRI nude mice
    Colorectal CUCRC006 Athymic nude mice
    Colorectal CUCRC026 Athymic nude mice
    Colorectal CUCRC036 Athymic nude mice
    Colorectal CUCRC042 Athymic nude mice
    Colorectal CUCRC047 Athymic nude mice
    Colorectal CUCRC040 (KRAS mutant PDX) Athymic nude mice
    Colorectal CUCRC042 (KRAS/PIK3CA mutant PDX) Athymic nude mice
    Colorectal CUCRC108 (KRAS mutant PDX) Athymic nude mice
    Colorectal CUCRC125 Athymic nude mice
    Colorectal PDX
    Glioblastoma GMB-05 NOD.SCID mice
    Glioblastoma GMB-06 NOD.SCID mice
    Glioblastoma GMB-07 NOD.SCID mice
    Glioma GMB-derived NOD.SCID mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) PDX-SE1 NOD.SCID mice
    Head & Neck Squamous Cell Carcinoma (HNSCC) PDX-SE3 NOD.SCID mice
    Liver AKH23 SCID/beige mice
    Liver KFJ18 SCID/beige mice
    Lung (NSCLC PDX) NOD.SCID mice
    Lung (SCLC PDX)
    Lung p2 SCLC PDXact NOD.SCID mice
    Melanoma H1 NOD.SCID mice
    Melanoma H2 NOD.SCID mice
    Melanoma H3 NOD.SCID mice
    Melanoma H10 NOD.SCID mice
    Neuroblastoma SK-N-SH
    Ovarian (ovarian, primary peritoneal, or fallopian tube cancer PDX)
    Ovarian PAPP-A SCID/beige mice
    Ovarian OVCAR-8 SCID/beige mice
    Ovarian PH026 SCID/beige mice
    Ovarian PH048 SCID/beige mice
    Ovarian PH212 SCID/beige mice
    Pancreatic JH033 Athymic nude mice
    Pancreatic Panc194 Athymic nude mice
    Prostate KRAS PANC-1 SCID/beige mice
    Prostate 1B Athymic nude mice
    Prostate 2B Athymic nude mice
    Prostate 2T Athymic nude mice
    Prostate 3B Athymic nude mice
    Prostate 3T Athymic nude mice
    Prostate 4B Athymic nude mice
    Prostate 4T Athymic nude mice
    Prostate LuCaP35CR Athymic nude mice
    Prostate C4-2B
    Prostate DU145
    Prostate C4-2B-TaxR
    Prostate DU145-TaxR
    Sarcoma (Chondrosarcoma PDX) Athymic nude mice
    Sarcoma (Ewing sarcoma PDX) Athymic nude mice
    Sarcoma (Leiomyosarcoma PDX) Athymic nude mice
    Sarcoma (Liposarcoma PDX) Athymic nude mice
    Sarcoma (Multifocal sarcoma PDX) Athymic nude mice
    Sarcoma (Myxoma PDX) Athymic nude mice
    Sarcoma (Phyllodes sarcoma PDX) Athymic nude mice
    Sarcoma (Rhabdomyosarcoma PDX) Athymic nude mice
    Sarcoma (Small round cell sarcoma PDX) Athymic nude mice
    Sarcoma (Spindle cell sarcoma PDX) Athymic nude mice
    Sarcoma (Synovial sarcoma PDX) Athymic nude mice
    Kidney (Renal Cell Carcinoma PDX) Athymic nude mice
    Oral (Floor of Mouth Squamous Cell Carcinoma PDX) Athymic nude mice
    Thyroid BCPAP nude
    Thyroid TPC-1 SCID/beige mice nude
    Thyroid CUTC5
    Thyroid CUTC48
    Thyroid CUTC60
    Thyroid CUTC61
    Rodent Tissue
    Bladder (rat) NBT-II Athymic nude mice nude
    Bladder AY-27 Fischer 344
    Brain RT2-GFP Fischer 344
    Brain Tu-2449
    Brain (murine glioblastoma) GL-261 C57BL/6 inbred mice
    Brain (murine glioma) RG2 RAG2 KO(SD)
    Brain (rat glioma) C6
    Breast 4T1-luc2 BALB/c inbred mice
    Breast 4T1
    Breast T11 SCID/beige mice
    Breast 67NR SCID/beige mice
    Breast JC
    Breast MMTV-PyMT Athymic nude mice
    Breast P53-null MECs BALB/c inbred mice
    Breast 4T07
    Carcinoma B4B8 BALB/c inbred mice
    Carcinoma LY2 BALB/c inbred mice
    Carcinoma (murine mammary) 4T1 SCID/beige mice
    Carcinoma (murine) LL/2 SCID/beige mice
    Carcinoma (murine) KIL C.2
    Colon AOM-induced colon tumors Fischer 344
    Colon CT26
    Colon CT26CL25 BALB/c inbred mice
    Colon CT26 BALB/c inbred mice
    Colon C51 mouse colon cancer cells nude
    Colorectal AOM-induced colon tumors Fischer 344
    Embryo (murine) Src3T3 Athymic nude mice nude
    Esophageal NMBA-induced esophageal tumors Fischer 344
    Liver MC38-Luc1 C57BL/6 inbred mice
    Lung (murine) LL2 Athymic nude mice
    Lung Cancer LL C57BL/6 inbred mice
    Lymphoma EL4
    Lymphoma E.G7-OVA C57BL/6 inbred mice
    Lymphoma E.G7
    Mammary MNU-induced mammary tumors Sprague Dawley
    Mammary (rat) DMBA-induced rat mammary carcinoma Athymic nude mice
    Mammary (rat) 17β-estradiol-induced mammary tumors Brown Norway
    Melanoma B16
    Melanoma RBE4 NOD.SCID mice
    Melanoma B16-F10 C57BL/6 inbred mice
    Melanoma B16-OVA C57BL/6 inbred mice
    Melanoma B16.OVA C57BL/6 inbred mice
    Melanoma B16.F10 C57BL/6 inbred mice
    Melanoma (murine) B16F10
    Oral (murine) PCI-13 NOD.SCID mice
    Ovarian (rat) PROb Athymic nude mice
    Pancreatic Panc02
    Prostate Tgfbr2floxE2 C57BL/6 inbred mice
    Canine Tissue
    Prostate Ace-1 nude
    Melanoma MDCK NOD.SCID mice
    Melanoma MDCK-II NOD.SCID mice

    References

    1. Verhoef, J.J.C. et al., Radiat Oncol, 2, 38 (2007). Netherlands (athymic nude mice )
    2. Ponthan, F. et al., Oncol Reports, 10, 1587 (2003). Netherlands (athymic nude rats)
    3. Rubenstein, J.L. et al., Neoplasia, 2(4), 306 (2000). North America (athymic nude rats)
    4. Plunkett, R.J. et al., J Neurosurg, 90, 1071 (1999). North America (athymic nude rats)
    5. Brignole, C. et al., J Natl Cancer Inst, 96, 1171 (2004). Italy (athymic nude mice, SCID-beige mice)
    6. Pan, Y. et al., Breast Cancer Res, 8, R63 (2006). North America (athymic nude mice)
    7. Sartorius, C.A. et al., Cancer Res, 65(21), 9779 (2005). North America (athymic nude mice)
    8. Arteaga, C.L. et al., Cell Growth & Diff, 4, 193 (1993). North America (athymic nude mice)
    9. Hardman, E.W. et al., Cancer Cell Intl, 2, 10 (2002). North America (athymic nude mice)
    10. Amiekhosravi, A. et al., Thromb Haemost, 90, 549 (2003). North America (athymic nude mice)
    11. Dikmen, Z.G. et al., Turk J Med Sci, 35, 65 (2005). North America (athymic nude mice )
    12. Richert, M.M. et al., Breast Cancer Res, 7, R819 (2005). North America (athymic nude mice)
    13. Burch, S. et al., J Biomedical Optics, 10, 034011-1-13 (2005). North America (athymic nude rats)
    14. Blask, D.E. et al., Breast Cancer Res, And Treatment 79, 313 (2003). North America (athymic nude rats)
    15. Bäuerle, T. et al., Intl J Oncol, 28, 573 (2006). Germany (athymic nude rats)
    16. Prewett, M.C. et al., Clin Cancer Res, 8, 994 (2002). North America (athymic nude mice)
    17. Sheng, H. et al., J Clin Invest, 99, 2254 (1997). North America (athymic nude mice )
    18. Yang, M. et al., Proc Nat Acad Sci, 102, 6027 (2005). North America (athymic nude mice )
    19. Park, B.H. et al., Proc Natl Acad Sci, 98, 2598 (2001). North America (athymic nude mice )
    20. Kruskal, J.B. et al., Radiology, 215, 852 (2000). North America (athymic nude mice)
    21. Tijink, B.M. et al., J Nucl Med, 47, 1127 (2006). EU (athymic nude mice)
    22. Marchal, F. et al., Oncology Reports, 14, 1203 (2005). France (athymic nude rats)
    23. Wang, M. et al., World J Gastroenterol, 9(11), 2627 (2003). France (athymic nude rats)
    24. Dauchy, R. T. et al., Cancer Letters, 209, 7 (2004). North America (athymic nude rats)
    25. Svechnikova, I. et al., Intl J Oncol, 22, 579 (2003). Netherlands (athymic nude rats)
    26. Till, H. et al., Surgical Endoscopy, 19, 1483 (2005). Germany (athymic nude rats)
    27. Barone, T.A. et al., Blood, 90, 298 (1997). North America (athymic nude rats)
    28. Francisco, J.A. et al., Blood, 102, 1458 (2003). North America (SCID mice)
    29. Geldhof, A.B. et al., Clin & Experimental Metastasis, 16(5), 447 (1998). North America (ICR-SCID mice)
    30. Wang, M. et al., Blood, 109, 5455 (2007). North America (SCID mice)
    31. Zou, Y. et al., J Natl Cancer Inst, 90, 1130 (1998). North America (athymic nude mice)
    32. Maneckjee, R. and Minna, J.D., Proc Natl Acad Sci, 89, 1169 (1992). North America (athymic nude mice)
    33. Weinberg, O.K. et al., Cancer Res, 65, 11287 (2005). North America (athymic nude mice)
    34. Boehle, A.S. et al., Intl J Cancer, 94, 420 (2001). Germany (SCID-beige mice)
    35. Horton, H.M. et al., Proc Natl Acad Sci, 96, 1553 (1999). North America (athymic nude mice, beige-nude-xid mice)
    36. Malafa, M.P. et al., Annals of Surgical Oncol, 9(10), 1023 (2002). North America (athymic nude mice)
    37. Bromberg, M.E. et al., Proc Natl Acad Sci, USA 92, 8205 (1995). North America (SCID mice)
    38. Modesitt, S.C. et al., Clin Cancer Res, 7,1487 (2001). North America (athymic nude mice)
    39. Duyndam, M.C.A. et al., Am J Pathol, 160, 537 (2002). Netherlands (athymic nude mice)
    40. Gossmann, A. et al., J Obstetrics and Gynecol, 183, 956 (2000). North America (athymic nude rats)
    41. Mahasreshti, P.J. et al., Clin Cancer Res, 7, 2057 (2001). North America (SCID mice)
    42. Fukasawa, M. and Murray, K., Clin Cancer Res, 10, 3327 (2004). North America (athymic nude mice)
    43. Koehler, J.A. and Drucker, D.J., Diabetes, 55, 1369 (2006). North America (athymic nude mice)
    44. Weber, D. et al., Cancer Res, 60, 5284 (2000). North America (athymic nude mice)
    45. Boenicke, L. et al., J Mol Med, 81, 205 (2003). Germany (SCID mice)
    46. Zhang, X. et al., J Nucl Med, 47, 492 (2006). North America (athymic nude mice)
    47. Tuomela, J.M. et al., BMC Cancer, 8, 81 (2008). Germany (athymic nude mice)
    48. Srivastava, S.K. et al., Carcinogenesis, 24(10), 1665 (2003). North America (athymic nude mice)
    49. Hillman, G.G. et al., Mol Cancer Ther, 3, 1271 (2004). North America (athymic nude mice)
    50. Graff, J.R. et al., J Biol Chem, 275, 24500 (2000). North America (athymic nude mice)
    51. Gregory, C.W. et al., Cancer Res, 61, 2892 (2001). North America (athymic nude mice)
    52. Cabrera, G. et al., Mol Cancer, 5, 32 doi:10.1186/1476-4598-5-32 (2006). North America (athymic nude rats)
    53. Adkins, H.B. et al., J Clin Invest, 112, 575 (2003). North America (athymic nude mice)
    54. Weydert, C. et al., Mol Cancer Ther, 2, 361 (2003). North America (athymic nude mice)
    55. Fu, X, Tao, L and Zhang, X., Cancer Gene Therapy, 14, 480 (2007). North America (athymic nude mice)
    56. Sun, L. and Chen, C., J Biol Chem, 272(40), 25367 (1997). North America (athymic nude mice)
    57. Sutherland, M.K. et al., mAbs 1(5), 481 (2009). North America (SCID mice)
    58. Lai, C.P.K. et al., Cancer Res, 67(4), 1545 (2007). North America (athymic nude mice)
    59. Folkins, C. et al., Cancer Res, 69(18), 7243 (2009). North America (athymic nude mice)
    60. Ueno, N.T. et al., Cancer Res, 62, 6712 (2002). North America (athymic nude mice)
    61. agata, Y. et al., Cancer Cell, 6, 117 (2004). North America (athymic nude mice )
    62. Puig, T. et al., Clin. Cancer Res., 15, 7608 (2009). UK (BALB/c nude mice )
    63. Liu, Z. et al., Nano Res, 3(3), 222 (2010). North America (athymic nude mice)
    64. Chandarlapaty, S. et al., Oncogene, 29, 325 (2010). EU (athymic nude mice)
    65. Simons, A.L. et al., Int J Radiat Oncol Biol Phys, 69(4), 1222 (2007). North America (athymic nude mice)
    66. Want, D. et al., Clin Cancer Res, 14(19), 6228 (2008). North America (athymic nude mice)
    67. LoTempio, M.M. et al., Clin Cancer Res, 11(19), 6994 (2005). North America (athymic nude mice)
    68. Barok, M. et al., Mol Cancer Ther, 6(7), 2065 (2007). Netherlands (NMRI nude mice, SCID mice)
    69. Tanner, M. et al., Mol Cancer Ther, 3(12), 1585 (2004). Netherlands (NMRI nude mice)
    70. Tanner, M. et al., Annals of Oncol, 16, 273 (2005). Netherlands (NMRI nude mice)
    71. Lin, L. et al., Neoplasia, 12(1), 39 (2010). North America (athymic nude mice)
    72. Moulder, S.L. et al., Cancer Res, 61, 8887 (2001). North America (athymic nude mice)
    73. Zhang, X. et al., Clin Cancer Res, 11, 323 (2005). North America (athymic nude mice)
    74. Campbell, R.A. et al., Int J Oncol, 28(6), 1409 (2006). North America (athymic nude mice)
    75. Chen, H. et al., Blood, 113, 1992 (2009). North America (athymic nude mice)
    76. Dingli, D. et al., Clin Cancer Res, 8, 3948 (2002). North America (SCID mice)
    77. Chavez-Blanco, A. et al., Cancer Cell Int, 6, 2 (2006). North America (athymic nude mice)
    78. Ferretti, S. et al., Neoplasia, 11(9), 874 (2009). EU (athymic nude mice)
    79. Heikkilä, J.E. et al., PLoS ONE, 5(1), e8603 (2010). UK (BALB/c nude mice)
    80. Xiao, W. et al., Eur J Nucl Med Mol Imaging, 36, 94 (2009). North America (athymic nude mice)
    81. Li, L. et al., Clin Cancer Res, 13(7), 2178 (2007). North America (athymic nude mice)
    82. Hsu, A.R. et al., J Nucl Med, 48, 445 (2007). North America (athymic nude mice)
    83. Chen, X. et al., J Nucl Med, 45, 1776 (2004). North America (athymic nude mice)
    84. Menon, C. et al., Am J Physiol Heart Circ Physiol, 24, H317 (2003). North America (athymic nude mice)
    85. Ueno, T. et al., Mol Cancer Ther, 5(3), 732 (2006). North America (athymic nude rats)
    86. Goyeneche, A.A. et al., Clin Cancer Res, 13(11), 3370 (2007). North America (athymic nude mice)
    87. Li, D. et al., Oncogene, 21, 2805 (2002). North America (athymic nude mice)
    88. Boehle, A.S. et al., Ann Thorac Surg, 69, 1010 (2000). Germany (SCID-beige mice)
    89. Kurdow, R. et al., Ann Thorac Surg, 73, 905 (2002). Germany (SCID-beige mice)
    90. Hamblett, K.J. et al., Clin Cancer Res, 10, 7063 (2004). North America (SCID mice)
    91. Santin, A.D. et al., Cancer Res, 65(10), 4334 (2005). North America (SCID mice)
    92. Nilsson, M.B. et al., J Biol Chem, 282(41), 29919 (2007). North America (SCID mice)
    93. Spaeth, E.L. et al., PloS ONE, 4(4), e4992 (2009). North America (SCID mice)
    94. Bruckheimer, E.M. et al., Neoplasia, 11(6), 509 (2009). North America (SCID mice, NOD.SCID mice)
    95. Nagengast, W.B. et al., J Nucl Med, 48, 1313 (2007). Netherlands (athymic nude mice)
    96. Auzenne, E. et al., Neoplasia, 9(6), 479 (2007). North America (athymic nude mice)
    97. Rodrigues-Ferreira, S. et al., PLoS ONE, 4(10), e7239 (2009). UK (SCID mice)
    98. Houba, P.H.J. et al., British J Cancer, 78(12), 1600 (1998). Netherlands (athymic nude mice)
    99. Vingerhoeds, M.H. et al., British J Cancer, 74, 1023 (1996). Netherlands (NMRI nude mice)
    100. Le Pimpec-Barthes, F. et al., British J Cancer, 81(8), 1344 (1999). EU (athymic nude rats)
    101. Fu, X. et al., Mol Ther, 7(6), 748 (2003). North America (athymic nude mice)
    102. Folberg, R. et al., Invest Ophthalmol Vis Sci, 48(7), 2967 (2007). North America (SCID mice)
    103. Swami S., et.al., Horm Cancer. 2011 June 1; 2(3): 190-202. North America (athymic nude mice)
    104. Kiyama, S. et al., Cancer Res, 63, 3575 (2003). North America (athymic nude mice)
    105. Elsadek, B. et al., Prostate Cancer and Prostatic Diseases, 14, 14 (2011). Germany (SCID mice)
    106. Sun, S. et al., J Clin Invest, 120(8), 2715 (2010). North America (athymic nude mice)
    107. Li, T.H. et al., Nucleic Acids Res, 35(8), 2767 (2007). North America (athymic nude mice)
    108. Pan, J. et al., PLoS ONE, 5(10), e13298. doi:10.1371/journal.pone.0013298 (2010). North America (athymic nude mice)
    109. Määttä, A.-M. et al., Int J Cancer, 121, 863 (2007). Netherlands (NMRI nude mice)
    110. Jarzynka, M.J. et al., Int J Oncol, 28(2), 337 (2006). North America (athymic nude mice)
    111. Bruckheimer, E.M. et al., Neoplasia, 11(6), 509 (2009). North America (athymic nude mice, SCID mice, NOD.SCID mice)
    112. Yi, J. M. et al., Cancer Res, 68(19), 8094 (2008). North America (SCID mice)
    113. Ovalle, S. et al., Int J Cancer, 121, 2140 (2007). Spain (athymic nude mice )
    114. Schleup, T. et al., Clin Cancer Res, 15, 181 (2009). North America (athymic nude mice )
    115. Orian-Rousseau, V. et al., Int J Cancer, 113, 699 (2005). Germany (SCID-beige mice)
    116. Zielske, S.P. et al., Int J Radiat Oncol Biol Phys, 75(3), 843 (2009). North America (athymic nude mice)
    117. Kaafarani, I. et al., FASEBJ, 23, doi: 10.1096/fj.08-127852 (2009). France (NMRI nude mice)
    118. Koskimaki, J. E. et al., BMC Cancer, 10, 29 (2010). North America (athymic nude mice)
    119. Jakubezak, J.L. et al., Cancer Res, 63, 1490 (2003). North America (athymic nude mice)
    120. McEarchern, J.A. et al., Clin Cancer Res, 14, 7763 (2008). North America (SCID mice)
    121. Kelley, S.K. et al., Br J Pharmacol, 148(8), 1116 (2006). North America (SCID mice)
    122. Smrekar, B. et al., Gene Therapy, 10, 1079 (2003). UK; Germany (SCID mice)
    123. Tremmel, M. et al., Blood, 114(25), 5236 (2009). Germany (athymic nude mice)
    124. Cuesta, Á.M., et al., PLoS ONE, 4(4), e5381. doi:10.1371/journal.pone.0005381 (2009). Spain (athymic nude mice)
    125. Pastorino, F. et al., Cancer Res, 63, 86 (2003). Italy (athymic nude mice )
    126. Kelly, P. et al., British J Cancer, 103, 232 (2010). UK (SCID mice)
    127. Larkin, J.O. et al., Ultrasound Med Biol, 34(3), 406 (2008). UK (MF1 nude mice)
    128. Kang, K.S., et al., PLoS ONE 5(4): e10296. doi:10.1371/journal.pone.0010296 (2010). North America (athymic nude mice)
    129. Shah, G.V. et al., Endocrine-Related Cancer, 15, 953 (2008). North America (athymic nude mice)
    130. Lipnik, K. et al., Virol, 349, 121 (2006). Germany (SCID-beige mice)
    131. Agu, C.A. et al., J Gene Med, 8, 229 (2006). Germany (SCID-beige mice)
    132. Rhodes, L.V. et al., Breast Cancer Res Treat, 121(2), 293 (2010). North America (SCID-beige mice)
    133. Barone, T.A. et al., J Neuro-Oncol, 95(1), 37 (2009). North America (athymic nude rats)
    134. Nanda, D. et al., Cancer Res, 61, 8743 (2001). UK (beige-nude-xid mice)
    135. Markaverich, B. et al., Eviron Health Perspect,110, 169 (2002). North America (athymic nude mice)
    136. Stan, S.D. et al., Cancer Res, 68(18), 7661 (2008). North America (athymic nude mice)
    137. Shashkova, E.V. et al., Cancer Res, 68, 5896 (2008). North America (athymic nude mice)
    138. Larkin, J.O. et al., Ann Surg, 245(3), 469 (2007). UK (BALB/c nude mice, MF1 nude mice)
    139. Loebinger, M.R. et al., Cancer Res, 69(23), 8862 (2009). UK (NOD.SCID mice)
    140. Cai, W. et al., J Nucl Med, 48, 304 (2007). North America (athymic nude mice)
    141. Squires, M.S. et al., Mol Cancer, 8(2), 324 (2009). UK (BALB/c nude mice)
    142. Airoldi, I. et al., PLoS ONE, 4(7), e6119. doi:10.1371/journal.pone.0006119 (2009). Italy (NOD.SCID mice)
    143. Lee, F.Y.F. et al., Cancer Chemother Pharmacol, 63, 201 (2009). North America (athymic nude mice, SCID-beige mice)
    144. Yang, J. et al., Cancer Cell, 10, 295 (2006). North America (SCID mice)
    145. Dauchy, R.T. et al., J Pineal Res, 47, 32 (2009). North America (athymic nude rat)
    146. Wu, J. et al., Cancer Res, 71, 2622 (2011). North America (athymic nude rat)
    147. Sharma, S. et al., Ejc Supplements, ISSN:13596349, 8(7), 66 (2010). North America (athymic nude mice)
    148. Hadaschik, B.A. et al., Cancer Res, 68, 4506 (2008). North America (athymic nude mice)
    149. Chadalapaka, G. et al., Cancer Res, 68(13), 5345 (2008). North America (athymic nude mice)
    150. Cho, S.D. et al., Mol Pharmacol, 77(3), 396 (2010). North America (athymic nude mice)
    151. Jutooru, I. et al., Exp Cell Res, 316(13), 2174 (2010). North America (athymic nude mice)
    152. Zawel, L. et al., PNAS, 99(5), 2848 (2002). North America (athymic nude mice)
    153. Donawho, C.K. et al., Clin Cancer Res, 13(9), 2728 (2007). North America (athymic nude mice)
    154. Rockett, J.C. et al., Br J Cancer, 75(2), 258 (1997). UK (athymic nude mice)
    155. Kan, T. et al., Gastroenterol, 136(5), 1689 (2009) North America (athymic nude mice)
    156. Zhang, S. et al. Mol Cancer Ther, 11, 108 (2012). North America (athymic nude mice)
    157. Zhang, K.-X. et al., Breast Cancer Res Treat, 125, 89 (2011). North America (athymic nude mice)
    158. Zhang, K.-X. et al., Breast Cancer Res Treat, 125, 89 (2011). North America (athymic nude mice)
    159. Liu, Z. et al., Nano Res, 3, 222 (2010). North America (athymic nude mice)
    160. Rimawi, M.R. et al., Clin Cancer Res, 17, 1351 (2011). North America (athymic nude mice)
    161. Zhao, Y. et al., Cancer Res, 71, 4585 (2011). North America (athymic nude mice)
    162. Scaltriti, M. et al., Mol Cancer Ther, 10, 817 (2011). North America (athymic nude mice)
    163. Massey, A.J. et al., Mol Cancer Ther, 9, 906 (2010). Switzerland (athymic nude mice)
    164. Maira, S.-M. et al., Mol Cancer Ther, doi:10.1158/1535-7163.MCT-11-0474. Switzerland (athymic nude mice)
    165. O'Donovan, N. et al., Invest New Drugs, 29, 752 (2011). UK (BALB/c nude mice)
    166. Chao, O. et al., J Med Chem, 52, 7808 (2009). North America (athymic nude mice)
    167. Yu, Y.A. et al., Mol Cancer Ther, 8, 141 (2009). North America (athymic nude mice)
    168. Haddad, D. et al., J Translational Med, 9, 36 (2011). North America (athymic nude mice)
    169. Gourdeau, H. et al., Cancer Chemother Pharmacol, 61, 911 (2008). North America (athymic nude mice)
    170. Liu, T.W. et al., Bioconjugate Chem, 22, 1021 (2011). North America (athymic nude mice, athymic nude rats)
    171. Alzani, R. et al., Exp Hematol, 38, 259 (2010). Italy (SCID mice)
    172. Sehdev, V. et al., Mol Cancer Ther, doi: 10.1158/1535-7163.MCT-11-0623 (2012). North America (athymic nude mice)
    173. Bralten, L.B.C. et al., Ann Neurol, 69, 455 (2011). Netherlands (SCID mice)
    174. Ayuzawa, R. et al., Cancer Letters,280, 31 (2009). North America (SCID mice)
    175. Barok, M. et al., Cancer Letters, 306, 171 (2011). Netherlands (SCID mice)
    176. Zeng, Q. et al., Euro J Cancer, 46, 1132 (2010). North America (athymic nude mice)
    177. Pais, A. et al. Cancer Res, 71(24), 7387 (2011). Israel (SCID mice)
    178. Junttila, T.T. et al., Cancer Cell, 15, 429 (2009). North America (SCID mice)
    179. Daigle, S. R. et al., Cancer Cell, 20, 53 (2011). North America (athymic nude mice)
    180. Patyna, S. et al. Mol Cancer Ther, 5, 1774 (2006). North America (athymic nude mice, NOD.SCID mice)
    181. Zarrinkar, P.P. et al. Blood, 114(14), 2984 (2009). North America (NOD.SCID mice)
    182. Mertz, J.A. et al., PNAS, 108(40), 16669 (2011). North America (athymic nude mice)
    183. Tokalov, S.V. et al., J Biomed and Biotechnol, Article ID 580531, 4 p doi:10.1155/2010/580531 (2010). Germany (athymic nude rats)
    184. Anastas, J.N. et al., Oncogene, doi:10.1038/onc.2011.528 (2011). North America (athymic nude mice)
    185. Mitra, A. et al., Breast Cancer Res, 10:R22 (2008). North America (athymic nude mice)
    186. Volk, L.D. et al., Neoplasia, 10(6), 613 (2008). North America (athymic nude mice)
    187. Hiraga, T. et al., Cancer Res, 61, 4418 (2001). North America (athymic nude mice)
    188. Mukhopadhyay, K.D. et al., PLoS ONE, 6(6), e20473 (2011). North America (athymic nude mice)
    189. Bandyopadhyay, A. et al., PLoS ONE, 5(4), e10365 (2010). North America (athymic nude mice)
    190. Walsh, C. et al., Cancer Biol Ther, 9(10), 778 (2010). North America (athymic nude mice, BALB/c SCID mice)
    191. Lee, S.-M. et al., ACS Nano, 4(9), 4971 (2010). North America (athymic nude mice)
    192. Kerjaschki, D. et al. J Clin Invest, 121(5), 2000 (2011). Germany (SCID mice)
    193. Whitehurst, B. et al., Int J Cancer, 121, 2181 (2007). North America (SCID mice)
    194. Graeser, R. et al., Int J Cancer, 122, 1145 (2008). Germany (SCID mice)
    195. Gomez-Manzano, C. et al., Neuro-Oncol, 10, 940 (2008). North America (athymic nude mice)
    196. et al., Cancer Gene Ther, 12, 947 (2005). Germany (athymic nude mice)
    197. Verheije, M.H. et al., J Virol, 83(15), 7507 (2009). Netherlands (athymic nude mice)
    198. Ke, L.D. et al., Clin Cancer Res, 6, 2562 (2000). North America (athymic nude mice)
    199. Clark, A.J. et al., J Neurosurg, 112, 18 (2010). North America (athymic nude mice)
    200. Calzolari, A. et al., Transl Oncol, 3(2), 123 (2010). Italy (athymic nude mice)
    201. Schiappacassi, M. et al., Mol Cancer Ther, 7(5), 1164 (2008). Italy (athymic nude mice)
    202. Yoon, H. et al., J Cellular Biochem, 108, 832 (2009). North America (athymic nude mice)
    203. Abourbeh, G. et al., Nucl Med and Biol, 34, 55 (2007). Israel (athymic nude mice)
    204. Benny, O. et al., FASEB J, 22, 488 (2008). Israel (CD-1 nude mice)
    205. Yin, S. et al., Neuro-Oncol, 12(1), 19 (2010). Sweden (athymic nude rats)
    206. Khan, Z. et al., Neuro-Oncol, 12(6), 549 Sweden (athymic nude rats)
    207. Buursma, A.R. et al., J Nucl Med, 46, 2068 (2005). Netherlands (athymic nude rats)
    208. Gunasekaran, K. et al., J Biol Chem, 285(25), 19637 (2010). North America (NOD.SCID mice)
    209. Li, J.-L. et al., Cancer Res, 67(23), 11244 (2007). Germany (BALB/c SCID mice)
    210. Holen I., et.al., Breast Cancer Research 2012, 14:R86. United Kingdom (BALB/c nude mice)
    211. Hennessy, B.T. et al. Clin Cancer Res, 13(24), 7421 (2007). North America (athymic nude mice)
    212. Nakamori, M. et al., 9, 2727 (2003). North America (athymic nude mice)
    213. Ma, L. et al., Acta Biochim Biophys Sin, 42(9), 593 (2010). Asia (BALB/c nude mice)
    214. Shao, M. et al., Cancer Res, 69, 9192 (2009). North America (BALB/c nude mice)
    215. Lljin, K. et al., Clin Cancer Res, 15(19), 6070 (2009). Finland (athymic nude mice)
    216. Izhak, L. et al., J Immunol, 183, 732 (2009). Israel (SCID-beige mice)
    217. Inbar-Rozensal, D. et al., Breast Cancer Res, 11, R78 (2009). Israel (CD-1 nude mice)
    218. González, L. et al., J Biol Chem, 281(30), 20851 (2006). Spain (athymic nude mice)
    219. Wu, L. et al., Clin Cancer Res, 11(22), 8195 (2005). North America (athymic nude mice)
    220. Ghosh, A.K. et al., Cancer Res, 56(3), 718 (2005). North America (athymic nude mice)
    221. Tang, L. et al., J Nutr, 135, 287 (2005). North America (athymic nude mice)
    222. Fu, X. et al., Gene Ther, 10, 1458 (2003). North America (athymic nude mice)
    223. Shashkova, E.V. et al., Cancer Res, 68(14), 5896 (2008). North America (athymic nude mice)
    224. Ozawa, T. et al., Mol Pharmaceutics, 1(5), 368 (2004). North America (athymic nude rats)
    225. Bristol, J.A. et al., Mol Ther, 7(6), 755 (2003). North America (athymic nude mice)
    226. Folgiero, V. et al., Cell Death and Disease, 3, e440; doi:10.1038/cddis.2012.179 (2012). Italy (athymic nude mice, SCID mice)
    227. Jensen, M.R. et al., Breast Cancer Res, 10, R33 (2008). Switzerland (athymic nude mice)
    228. Golubovskaya, V.M. et al., J Med Chem, 51(23), 7405 (2008). North America (athymic nude mice)
    229. Hernandez-Alcoceba, R. et al., Human Gene Ther, 11, 2009 (2000). North America (athymic nude mice)
    230. Gutierrez, M.C. et al., JCO, 23(11), 2469 (2005). UK (athymic nude mice)
    231. Mahller, Y.Y. et al. PLoS ONE, 4(1):e4235. doi:10.1371/journal.pone.0004235 (2009). North America (athymic nude mice)
    232. Zhou, Y. et al., J Biol Chem, 286, 32843 (2011). North America (athymic nude mice)
    233. Salvatori, L. et al., PLoS ONE, 7(2), e31467. doi:10.1371/journal.pone.0031467 (2012). Italy (NOD.SCID mice)
    234. Londoño-Joshi, A.I. et al., Breast Cancer Res Treat, DOI 10.1007/s10549-011-1763-0 (2011). North America (NOD.SCID mice)
    235. Joseph, I. et al., Cancer Res, 70, 9494 (2010). North America (athymic nude mice)
    236. Lonardo, E. et al., Cell Stem Cell, 9(5), 433 (2011). Spain (athymic nude mice)
    237. Xiao, K. et al., Biomaterials, 30(30), 6006 (2009). North America (athymic nude mice)
    238. Li, Y. et al., J Immunol, 179, 4263 (2007). North America (SCID mice)
    239. Kumagai, T. et al., J Natl Cancer Inst, 95(12), 896 (2003). North America (beige-nude-xid mice)
    240. Kumagai, T. et al., Clin Cancer Res, 10, 1508 (2004). North America (beige-nude-xid mice)
    241. Audo, I. et al., Invest Ophthalmol Vis Sci, 44, 4192 (2003). North America (athymic nude mice)
    242. Cocco, C. et al., Clin Cancer Res, 16, 4188 (2010). Italy (NOD.SCID mice)
    243. Ayers, G.D. et al., J Ultrasound Med, 29(6), 891 (2010). North America (athymic nude mice)
    244. Ning, S. et al., Cancer Res, 70(19), OF1 (2010). North America (athymic nude rats)
    245. Yee, A.J.M. et al., Breast Cancer Res, 9(4), R47 (2007). North America (CD-1 nude mice, athymic nude rats )
    246. Mercatelli, N. et al., PLoS ONE, 3(12), e4029 (2008). Italy (SCID mice)
    247. Thallinger, C. et al., J Invest Dermatol, 127, 2411 (2007). Germany (SCID mice)
    248. Elsner, L. et al., J Immunol, 179, 5523 (2007). Germany (SCID-beige mice)
    249. Ren, G. et al., J Nucl Med, 50, 1692 (2009). North America (athymic nude mice)
    250. Morello, S. et al., Neoplasia, 13(4), 365 (2011). Italy (athymic nude mice)
    251. Stangl, S. et al., J Immunol, 176, 6270 (2006). Germany (SCID-beige mice)
    252. Phillips, G.D.L. et al., Cancer Res, 68, 9280 (2008). North America (beige-nude-xid mice)
    253. Lee-Hoeflich, S.T. et al., Cancer Res, 68, 5878 (2008). North America (beige-nude-xid mice)
    254. Yao, E. et al., Clin Cancer Res, 15, 4147 (2009). North America (beige-nude-xid mice)
    255. Allegrucci, C. et al., Mol Cancer, 10, 7 (2011). UK (MF1 nude mice)
    256. Brachmann, S.M. et al., PNAS, 106(52), 22299 (2009). North America (athymic nude mice)
    257. Hoeflich, K.P. et al., Clin Cancer Res, 15(14), 4649 (2009). North America (beige-nude-xid mice)
    258. Wong, T.W. et al., Clin Cancer Res, 12(20), 6186 (2006). North America (athymic nude mice)
    259. Halasi, M. et al., Cell Cycle, 9(4), 1214 (2010). North America (athymic nude mice)
    260. Zhang, S. et al., Endocrine-Related Cancer, 16, 835 (2009). North America (athymic nude mice)
    261. Hitosugi, T. et al., Mol Cell, 44(6), 864 (2011). North America (athymic nude mice)
    262. Jimeno, A. et al., Cancer Res, 65, 3003 (2005). North America (athymic nude mice)
    263. Mutsaers, A.J. et al., Clin Cancer Res, 15, 2397 (2009). North America (athymic nude mice)
    264. Guix, M. et al., J Clin Invest, 118(7), 2609 (2008). North America (athymic nude mice)
    265. Donnini, S. et al., Oncogene, doi:10.1038/onc.2011.503 (2011). Italy (athymic nude mice)
    266. Shir, A. et al., Clin Cancer Res, 17, 1033 (2011). Israel (NOD.SCID mice)
    267. Lee, C.M. et al., BMC Cancer, 10, 255 (2010). North America (athymic nude mice)
    268. Alameda, J.P. et al., Cell Death and Disease, 2, e208; doi:10.1038/cddis.2011.82 (2011). Spain (athymic nude mice)
    269. Valle BL, et al,. PLoS ONE 8(4): e61836 (2013). North America (athymic nude mice)
    270. Zhang C.C, et.al., Clinical Cancer Research 1-12; 2012. AACR. France (athymic nude mice)
    271. Carlson B. L, et.al., Curr Protoc Pharmocol. 2011 mar; Chapter 14: Unit 14. 16 (2011). North America (athymic nude mice)
    272. Calles A., et.al., Curr Protoc Pharmacol. 2013 Jun; Chapter 14: Unit 14.26 (2013). North America (NOD.SCID mice, athymic nude mice)
    273. Litzenburger BC., et.al., Clin Cancer Res April 15, 2011. 17; 2314. North America (NOD.SCID mice)
    274. Schott AF, et.al., Clin Cancer Res clincanres.3326.2012; Published Online First January 22, 2013. North America (SCID-beige mice)
    275. Leake K, et.al., PLoS ONE 7(4): e34582 (2012). North America (athymic nude mice)
    276. Zhao S, et.al., Oncogenesis (2013) 2, e76. North America (athymic nude mice)
    277. Hernandez JL, et.al., PLoS ONE 8(9): e72480 (2013). Spain (athymic nude mice)
    278. Jager W, el.al., PLoS ONE 8(3): e59536 (2013). North America (athymic nude mice)
    279. Shin D.H, et.al., JNCI J Natl Cancer Inst (2013). North America (athymic nude mice)
    280. Venkatasubbarao K, et.al., Molecular Cancer 2013, 12:104. North America (athymic nude mice)
    281. Rybczynska A.A, el.al., J Nucl Med September 1, 2013. The Netherlands (athymic nude mice)
    282. Gholami S, et.al., Breast Cancer Research 2013, 15:R26. North America (athymic nude mice)
    283. Zins K, et.al., Mol. Sci. 2013, 14, 17958-17971. Germany (athymic nude mice)
    284. Benavente S, et.al., Clin Cancer Res March 1, 2009 15; 1585. North America (athymic nude mice)
    285. Verhoeff JJC, et.al., Radiation Oncology 2007, 2:38. The Netherlands (athymic nude mice)
    286. Alessandro GD, et.al., Cell Death and Disease (2013) 4, e773. Italy (C.B-17 SCID mice)
    287. Jiang J., et.al., Oncol Rep. 2012 October; 28(4): 1139-1145. North America (athymic nude mice)
    288. Koht HE., et.al., The Journal of Clinical investigation. Volume 122, number 3, March 2012. North America (athymic nude mice)
    289. Barok M., et.al., Breast Cancer Research 2011, 13:R46. The Netherlands (C.B-17 SCID mice)
    290. Thorner Ar., et.al., PLoS ONE 5(10)e13073. North America (athymic nude mice)
    291. Hamada K., et.al., Gynecologic Oncology 99 (2005) S159-S165. North America (athymic nude rats)
    292. Lheureux S., et.al. Transl Oncol. 2013 October; 6(5): 586-595. North America (athymic nude rats)
    293. Millar HJ., et.al., Cancer Epidemiol Biomarkers Prev August 2008 17; 2180. North America (athymic nude rats)
    294. Ayers GD., et.al., JUM June 1, 2010 vol. 29 no. 6 891-90. North America (athymic nude mice)
    295. Cyran CC., et.al., PLoS ONE 8(9): e76009. North America (athymic nude rats)
    296. Daigle SR., et.al., Blood 2013 122: 1017-1025. North America (athymic nude rats)
    297. Jafri SH., et al., Journal of Experimental & Clinical Cancer Research 2010 29:87. North America (C.B-17 SCID mice)
    298. Dingli D., et al., Blood 2003 102: 489-496. North America (C.B-17 SCID mice)
    299. Green TP., et.al., Molecular Oncology 3 (2009), 248-261. France (athymic nude mice)
    300. Kreider JW., at al., Cancer Research 39, 273-276, January 1979. North America (athymic nude mice)
    301. Welsch CW, et.al, JNCI J Natl Cancer Inst (1987) 78 (3): 557-565. North America (athymic nude mice)
    302. Park SI., et.al., Curr Protoc Pharmacol. 2010 December 1; 51: 14.15-14.15.27. North America (athymic nude mice)
    303. Fernandes MS., et.al., Clin Cancer Res August 1, 2009 15; 4847. North America (C.B-17 SCID mice)
    304. Mundra JJ., et.al, JPET August 2012 vol. 342 no. 2 273-287. North America (SCID mice)
    305. Peng KW., et.al., Blood, 1 October 2001. Vol. 98. Numb. 7. North America (C.B-17 SCID mice)
    306. Bhatia N., et.al., J Invest Dermatol. 2013 March ; 133(3): 759-767. North America (athymic nude mice)
    307. Mischek D., et.al., Journal of Biomedicine and Biotechnology, Volume 2009 (2009), Article ID 437284. Germany (SCID-beige mice)
    308. Harrell JC., et.al., Cancer Res September 15, 2006 66; 9308. North America (athymic nude mice)
    309. Kumar S., et.al., Am J Pathol. 2003 December; 163(6): 2531-2541. North America (athymic nude mice)
    310. Schafer JM., et.al., Clin Cancer Res November 2000 6; 4373. North America (athymic nude mice)
    311. Gottardis MM., et.al., J Steroid Biochem. 1988;30(1-6):311-4. North America (athymic nude mice)
    312. O’Regan RM., et. al., JNCI J Natl Cancer Inst (2002) 94 (4): 274-283. North America (athymic nude mice)
    313. Morrison MM., J Clin Invest. 2013;123(10):4329-4343. North America (athymic nude mice)
    314. Suhong Xiao, et.al., The Journal of Biological Chemistry, 287, 12559-12577. North America (athymic nude mice, beige-nude-xid mice, SHrN® mice)
    315. Nguyen N, et.al., Cancer Prev Res. February 2011 4; 248. North America (athymic nude mice)
    316. Wang S, at.al., Cancer Gene Therapy (2002) 9, 1-8. doi:10.1038/sj.cgt.7700402. North America (athymic nude mice)
    317. Mathieu V.et.al, Oncotarget. Apr 2012; 3(4): 399-413. Germany (BALB/c SCID mice)
    318. Vaha-Koskela MJV., et.al., Cancer Res July 15, 2006 66; 7185. The Netherlands (SCID mice)
    319. Thallinger C., et.al., Journal of Investigative Dermatology (2003) 120, 1081-1086; doi:10.1046/j.1523-1747.2003.12252.x. Germany (C.B-17 SCID mice)
    320. Mathieu MG., et.al., Cell Death and Disease (2014) 5, e1061; doi:10.1038/cddis.2014.29 Published online 13 February 2014. United Kingdom (NOD.SCID mice)
    321. Hafner C., et.al., Int. J. Cancer: 114, 426-432 (2005). Germany (C.B-17 SCID mice)
    322. Luciani F, et.al., Oxford Journals Medicine JNCI J Natl Cancer Inst Volume 96, Issue 22 Pp. 1702-1713. Italy (C.B-17 SCID mice)
    323. Ong C.C., et.al., JNCI J Natl Cancer Inst (2013) djt054 doi: 10.1093/jnci/djt054. North America (beige-nude-xid mice)
    324. Lotan T., et.al., Cancer Res. Apr 1, 2008; 68(7): 2166-2175. North America (beige-nude-xid mice)
    325. Goel A., et.al., Blood 2007 110: 2342-2350. North America (beige-nude-xid mice)
    326. Zeng Y, et.al., J Biol Chem. Apr 22, 2011; 286(16): 13985-13994. North America (C.B-17 SCID mice)
    327. Hofmann M., et.al., Neoplasia (New York, N.Y.) (Impact Factor: 5.48). 09/2009; 11(8):812-22. Germany (NOD.SCID mice)
    328. Wang L., et.al., J Clin Neurosci. Jun 2012; 19 (6): 881-883. North America (NOD.SCID mice)
    329. Sharad S. Singhal, et.al., Cancer Res. May 15, 2009; 69(10): 4244-4251. North America (athymic nude mice)
    330. Amornphimoltham P., et.al., Clin Cancer Res. Mar 15, 2013; 19(6): 1375-1388. North America (athymic nude mice)
    331. Ricci-Vitiani L., et.al., Cell Death and Differentiation (2008) 15, 1491-1498; doi:10.1038/cdd.2008.72; published online 23 May 2008. Italy (athymic nude mice)
    332. Chiron M., et.al., Mol Cancer Ther June 2014 13; 1636. France (NMRI nude mice)
    333. Presnell SC., et.al., Am J Pathol. Sep 2001; 159(3): 855-860. North America (athymic nude mice)
    334. Stebbing J., et.al., Cancer. Volume 120, Issue 13, pages 2006-2015, 1 July 2014. North America (athymic nude mice)
    335. Weekes CD., et.al., Neoplasia. Aug 2012; 14(8): 69-701. North America (athymic nude mice)
    336. Pitts TM, et al., (2014) PLoS ONE 9(11): e113037. doi:10.1371/journal.pone.0113037. North America (athymic nude mice)
    337. Toussaint G.L., et.al., Molecular Cancer 2012, 11:32. North America (athymic nude mice)
    338. Bradshaw-Pierce E.L., et.al., Front. Pharmacol., 22 March 2013 | doi: 10.3389/fphar.2013.00022. North America (athymic nude mice)
    339. Petit V., et.al., Laboratory Investigation (2013) 93, 611-621; doi:10.1038/labinvest.2013.44; published online 4 March 2013. France (BALB/c nude mice)
    340. Anne L van de Ven, et.al., New Journal of Physics 15 (2013) 055004. North America (SCID-beige mice)
    341. Tchoghandjian A., et.al., Cell Death & Differentiation 21, 735-747 (May 2014). France (athymic nude mice)
    342. Veeravagu A., et.al., Clin Cancer Res November 15, 2008 14; 7330. North America (athymic nude mice)
    343. Mei J., et.al., Mol Cell Biol. Sep 2011; 31(7):3584-3592. North America (NOD.SCID mice)
    344. Wang J., et al., Cancer Cell 12, 239-251, September 2007. North America (athymic nude mice)
    345. Chisholm EJ., et.al., Cancer Res March 15, 2009 69; 2655. United Kingdom (BALB/c nude mice)
    346. Gao Z., et.al., International Journal of Cancer Volume 82, Issue 3, pages 346-352, 30 July 1999. North America (athymic nude mice)
    347. Dauchy RT., et.al., Comparative Medicine. Vol. 62, No 2, April 2012, pages 99 - 108. North America (athymic nude rats)
    348. Diagle SR., et.al., Blood: 122 (6). August 8, 2013. North America (athymic nude rats)
    349. Serra V, et.al., J Clin Invest. 2013;123(6):2551-2563. Spain (athymic nude mice, NMRI nude mice)
    350. Nephew KP., et. al., Cancer Res Published OnlineFirst July 17, 2014. North America (athymic nude mice)
    351. Pirazzoli V., et.al., Cell Reports 7, 999-1008, May 22, 2014. North America (athymic nude mice)
    352. Garcia R.R., et.al., Am J Clin Exp Urol 2014;2(1):82-91. North America (athymic nude mice)
    353. Nofiele JT., et.al., PLoS ONE 9(5): e97950. North America (athymic nude rats)
    354. Kolev, V.N., et al., Cancer Res January 15, 2015 75; 446. North America (SHrN™ mice, NOD.SCID mice)
    355. Colletti, JA II et al. G3 (Bethesda). 4 (2014) 1385-1394. North America (Brown Norway rats)
    356. Munson, JM., et al. Cancer Res. 73 (2013) 1536-1546. Swtizerland (Fisher 344 rats)
    357. Bhattacharya, A., et al. Carcinogenesis. 34 (2013) 2593-2599. North America (Fisher 344 rats)
    358. Janakiram, NB., et al., Cancer.Prev.Res.(Phila). 6 (2013) 1251-1261. North America (Fisher 344 rats)
    359. Ravillah, D., et al. et al., J.Pharmacol.Exp.Ther. 348 (2014) 59-68. North America (Fischer 344 rats)
    360. Shi, N., et al. Oncotarget. 5 (2014) 11333-11344. North America (Fischer 344 rats)
    361. Yang, L., et al., Int.J.Biochem.Mol.Biol. 3 (2012) 46-57. China (Fischer 344 rats)
    362. Stypula-Cyrus, Y., et al., FEBS Lett. 588 (2014) 829-835. North America (Fischer 344 rats)
    363. Khazal, KF., et al. Anticancer Res. 33 (2013) 1519-1523. North America (Spraque Dawley rats)
    364. Ouyang, N., et al. Int.J.Oncol. 42 (2013) 643-650. North America (Fischer 344 rats)
    365. Ostertang D., et.al., Neuro Oncol. 2012 February; 14(2): 145–159. North America (B6C3F1 mice)
    366. Rashid OM., et.al., Journal of Thoracic Disease. Vol 5, No 4 (August 2013). North America (BALB/c mice)
    367. Anz, D., et al, Int.J.Cancer 129 (2011) 2417-2426. Germany (C57BL/6 mice; BALB/c mice)
    368. Barbieri, A., et al, J.Cell.Mol.Med. 16 (2012) 920-926. Italy (C57BL/6 mice)
    369. Adinolfi, E., et al. Cancer Res. 72 (2012) 2957-2969. Italy (C57BL/6 mice; BALB/c mice)
    370. Gurzov, EN., et al. Oncogene 27 (2008) 641-652. Spain (C57BL/6 mice)
    371. Basile, LA., et al. J.Transl.Med. 6 (2008) 26-5876-6-26. North America (C57BL/6 mice)
    372. Balkow, S., et al, Exp.Dermatol. 18 (2009) 78-87. Germany (C57BL/6 mice)
    373. Llopiz, D., et al, Int.J.Cancer 125 (2009) 2614-2623. Spain (C57BL/6 mice)
    374. Jacobs, C., et al, Int.J.Cancer 128 (2011) 897-907. Germany (C57BL/6 mice)
    375. Aranda, F., et al, Cancer Res. 71 (2011) 3214-3224. 2011. Spain (C57BL/6 mice)
    376. Li, X., et al, Oncogene 27 (2008) 7118-7130. North America (C57BL/6 mice)
    377. Spitzer, D., et al, Cancer Res. 72 (2012) 201-209. North American (C57BL/6 mice)
    378. Uluckan, MC., et al, J.Cell.Biochem. 104 (2008) 1311-1323. North American (C57BL/6 mice)
    379. Bandyopadhyay, A., et al. PLoS One 5 (2010) e10365. North America (BALB/c mice)
    380. Cambien, B., et al, PLoS One 6 (2011) e28842. France (BALB/c mice)
    381. Cooney, CA., et al, Breast Cancer Res. 13 (2011) R58. North America (BALB/c mice)
    382. Israyelyan, A., et al. Virol.J. 5 (2008) 68-422X-5-68. North America (BALB/c mice)
    383. Jungwirth, U., et al. et al, Mol.Pharmacol. 81 (2012) 719-728. Austria (BALB/c mice)
    384. Lapteva, N., et al. J.Immunother. 32 (2009) 145-156. North America (BALB/c mice, C57BL/6J mice)
    385. Mojic, M., et al. Mol.Pharmacol. 82 (2012) 700-710. Serbia (BALB/c mice)
    386. Qiao, Y., et al. Oncotarget 2 (2011) 59-68. North America (BALB/c mice)
    387. Vanrell, L., et al, Mol.Ther. 19 (2011) 1245-1253. Spain (BALB/c mice)
    388. Vigneswaran, N. et al. Exp.Mol.Pathol. 90 (2011) 215-225. North America (BALB/c mice)
    389. Walsh, C., et al, Cancer.Biol.Ther. 9 (2010) 778-790. North America (BALB/c mice)
    390. Zhang, M., et al, Cancer Res. 68 (2008) 4674-4682. North America (BALB/c mice)
    391. Zigmond, E., et al. PLoS One 6 (2011) e28858. Israel (BALB/c mice)
    392. Ganesh, S., et al. Mol Cancer Ther (2016) Jul 7. North America (athymic nude mice)
    393. Jiménez-Valerio, G. et al. Cell Rep. (2016) May 10; 15(6):1134-43. Spain (athymic nude mice)
    394. Zhao, S., et al., Clin Cancer Res. (2016) Jun 7. North America (athymic nude mice)
    395. Francis, DM., et al. Clin Cancer Res. (2016) Feb 1; 22(3):633-43. North America (athymic nude mice)
    396. Crottès D., et al. Cancer Res. 2016 Feb 1; 76(3):607-18. France (SHrN™ mice)
    397. Kathagen-Buhmann A., et al. Neuro Oncol. 2016 Feb 24. Germany (SHrN™ mice)
    398. Jones R.J., et al. Clin Cancer Res. 2016 Jun 13. North America (C.B-17 SCID mice)
    399. Alagpulinsa D.A., et al. Mol Cancer Ther. 2016 Feb; 15(2):241-50. North America (C.B-17 SCID mice)
    400. Halle B., et al. J Neurooncol. 2016 Jan; 126(1):47-55. Denmark (athymic nude rats)
    401. Debeb B.G., et al. J Natl Cancer Inst. 2016 Apr 13; 108(8). North America (SCID-beige mice)
    402. Hudson K., et al. Mol Cancer Ther. 2016 May; 15(5):877-89. United Kingdom (SCID-beige mice)
    403. Gravekamp, C., et al. (2004). Experimental Biology and Medicine, 229(7), 665-675. North America (BALB/c mice)
    404. Toussaint, M., et al. Theranostics, 2017; 7(2): 436-451. France (athymic nude rat)
    405. Li, R., et. al, Current Cancer Drug Targets, 2014, 14, 274-285. China (athymic nude mouse)
    406. Schoenfeld, J.D., et al. Redox Biol. 2018 Apr;14:417-422. North America (athymic nude mouse)
    407. Sciegienka S.J., et al. Free Radic Biol Med. 2017 Jul;108:354-361. North America (athymic nude mouse)
    408. Segatto, I., et al. Aging, 8(5), 958-976. United Kingdom (athymic nude mouse)
    409. Sen, T., et al. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 2017 23(20), 6239-6253. North America (athymic nude mouse)
    410. Shao, C., et al. J Biol Chem. 2015 Jan 23;290(4):2024-33. North America (athymic nude mouse)
    411. Stafman, L.L., et al. Oncotarget. 2018 Apr 27; 9(32): 22665–22679. North America (athymic nude mouse)
    412. Tan Q., et al. Br J Cancer. 2015 Mar 3; 112(5): 832–840. North America (athymic nude mouse)
    413. Toden S., et al. Oncotarget. 2016 Mar 29; 7(13): 16158–16171. North America (athymic nude mouse)
    414. Wang W., et al. J Neurosurg. 2018 Mar;128(3):695-700. North America (athymic nude mouse)
    415. Waters A.M., et al. Mol Cancer Ther. 2016 May; 15(5): 911–921. North America (athymic nude mouse)
    416. Yan H., et al. Oncotarget. 2016 Jul 12; 7(28): 43352–43362. North America (athymic nude mouse)
    417. Yan S.B., et al. Invest New Drugs. 2018; 36(4): 536–544. North America (athymic nude mouse)
    418. Yeo S.K., et al. Cancer Res. 2016 Jun 1; 76(11): 3397–3410. North America (athymic nude mouse)
    419. Zumwalt T.J., et al. Cancer Prev Res (Phila). 2017 Mar; 10(3): 208–218. North America (athymic nude mouse)
    420. Alexander M.S., et al. Cancer Res. 2018 Sep 25. pii: canres.1680.2018. North America (athymic nude mouse)
    421. Choi A.H., et al. Surgery. 2018 Feb;163(2):336-342. North America (athymic nude mouse)
    422. Donabedian P.L., et al. EJNMMI Res. 2018; 8: 59. North America (athymic nude mouse)
    423. Nguyen O.N., et al. Cancer Res. 2017 Mar 15;77(6):1427-1438. Europe (BALB/c mice)
    424. Barrett, J. A., et al. 2018. Cancer Gene Therapy, 25(5-6), 106-116. North American (C57BL/6 mice)
    425. Thisgaard, H., et al. 2016. Theranostics, 6(12), 2278-2291. Denmark (athymic nude rats)
    426. Buck, J. R., et al. 2015. PloS One, 10(10), e0141659. North America (athymic nude rats)
    427. Gruslova, A., 2015. Journal of Neuro-Oncology, 124(3), 365-372. North America (athymic nude rats)
    428. Qureshi-Baig, K., 2016. PloS One, 11(1), e0146052. Europe (NOD.SCID mice)
    429. Torres-Guzman, R., et al. 2017. Oncotarget, 8(41), 69493-69507. North America (NOD.SCID mice)
    430. Zhang, Y., et al. 2018. Nature Communications, 9(1), 4080-018-06177-2. North America (NOD.SCID mice)
    431. Banerjee, K., et al. 2018. Clinical Oncology and Research, 1(1). North America (NOD.SCID mice)
    432. Frosina, G., et al. 2018. Scientific Reports, 8(1), 14191-018-32578-w. Europe (NOD.SCID mice)
    433. Gross, A. C., et al. 2018. JCI Insight, 3(16), 10.1172/jci.insight.99791. North America (C.B-17 SCID mice)
    434. Kryeziu, K., et al. 2016. Oncotarget, 7(19), 27379-27393. Europe (C.B-17 SCID mice)
    435. Ryan, M. C., et al. 2017. Blood, 130(18), 2018-2026. North America (C.B-17 SCID mice)
    436. Abrams, T., et al. 2018. Clinical Cancer Research, 24(17), 4297-4308. North America (SCID-beige mice)
    437. Butler, K. A., et al. 2017. Neoplasia (New York, N.Y.), 19(8), 628-636. North America (SCID-beige mice)
    438. Gill, S. E., et al. 2017. Oncotarget, 8(49), 85214-85223. North America (SCID-beige mice)
    439. Goncalves, A. F., et al. 2017. Nature Communications, 8(1), 1466-017-01514-3. Europe (SCID-beige mice)
    440. Park, J. H., et al. 2016. Cell Reports, 14(9), 2154-2165. North America (SCID-beige mice)
    441. Debeb, B. G., et al. 2016. Journal of the National Cancer Institute, 108(8). North America (SCID-beige mice)
    442. Song, W., et al. 2017. Oncogene, 36(40), 5620-5630. North America (NOD.SCID mice)
    443. Williams, A. P., et al. 2018. Translational Oncology, 12(1), 84-95. North America (athymic nude mouse)
    444. Yu, X., et al. 2018. International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 47(3), 957-971. Asia (athymic nude mouse)
    445. Ziegler, J., et al. (2017). Oncotarget, 8(42), 71833-71844. North America (athymic nude mouse)
    446. Van de Sande, L., et al. (2019). BMC Cancer, 19(1), 424. Belgium (athymic nude rats)
    447. Grünewald, S., et al. (2019). Int J Cancer, 145(5), 1346-1357. Germany (athymic nude rats)
    448. Owonikoko, T.K., et al. (2019). PLoS One, 14(2), e0206309. North America (athymic nude rats)
    449. Atkins, A., et al. (2019). Ann Biomed Eng, 47(4), 980-989. Canada (athymic nude rats)
    450. Vermandel, M., et al. (2019). Photodiagnosis Photodyn Ther, 25, 166-176. France (athymic nude rats)
    451. Vega, F.M., et al. (2019). EBioMedicine, 49, 82-95.Spain (CB-17 mice)
    452. Wang, Y., et al. (2019). Mol Cancer Ther, 19(2), 364-374. North America (CB-17 mice)
    453. Nguyen, T., et al. (2019). Cell Rep, 27(2), 491-501.e6 North America (CB-17 mice)
    454. Pfitzer, L., et al. (2019). Cell Death Dis, 10(4), 302. Germany (CB-17 mice)
    455. Fonti, C., et al. (2019). Int J Cancer, 145(5), 1299-1311. France (SCID-beige mice)
    456. Felder, M., et al. (2019). Gynecol Oncol, 152(3), 618-628 North America (SCID-beige mice)
    457. Torres, D., et al. (2019). PLoS One, 4(11), e0224564. North America (SCID-beige)
    458. Santiago-O'Farrill, J.M., et al. (2020). Bast RC Jr. Cancer, 126(4), 894-907. North America (SCID-beige)
    459. McDaid, W.J., et al. (2019). Nanoscale, 11(42), 20261-20273. UK (SCID-beige)
    460. Kanakkanthara, A., et al. (2019). Nat Commun, 10(1), 4632. North America (SCID-beige)
    461. Le Joncour, V., et al. (2019). Mol Cancer Ther, 18(10), 1721-1730. Finland (SCID-beige)
    462. Guerra-Rebollo, M., et al. (2019). Sci Rep, 9(1), 9549. Spain (SCID-beige)
    463. Owonikoko, T.K., et al. (2019). PLoS One, 14(2), e0206309. North America (SCID-beige)
    464. Wang, W., et al. (2019). J Clin Invest, 129(3), 1015-1029. North America (SCID-beige)
    465. Assimon, V.A., et al. (2019). ACS Chem Biol, 14(2), 236-244. North America (SCID-beige)
    466. Nachliely, M., et al. (2019). J Steroid Biochem Mol Biol, 188, 8-16. Israel (SCID-beige)
    467. Harris, F.R., et al. (2019). Mol Oncol, 13(2), 132-152. North America (SCID-beige)
    468. Adler-Levy, Y., et al. (2019). Sensors (Basel), 19(9). Israel (SCID-beige)
    469. Ramirez, A.B. et al. (2019). BMC Cancer, 19(1), 220. North America (SCID-beige)
    470. Schweppe, R.E., et al. (2019). Mol Cancer Res, 17(5), 1036-1048. North America (SCID-beige)
    471. Shamai ,Y., et al. (2019). Stem Cells, 37(2), 176-189. Israel (SCID-beige)
    472. Vandergaast, R., et al. (2019). Cancer Gene Ther, 27(3-4), 179-188. North America (SCID-beige)
    473. Kim, I.S., et al. (2019). Nat Cell Biol, 21(9), 1113-1126. North America (SCID-beige)
    474. Cai, D., et al. (2019). Nat Commun, 10(1), 4621. North America (CB-17)
    475. Ceresa, D., et al. (2019). Int J Mol Sci, 20(16). Italy (NOD.SCID)
    476. Aasen, S.N., et al. (2019). Mol Cancer Ther, 8(11), 2171-2181. Norway (NOD.SCID)
    477. Arroyo-Crespo, J.J., et al. (2019). Int J Cancer, 145(8), 2267-2281. Spain (NOD.SCID)
    478. Gatta, L.B., et al. (2019). Cancers (Basel), 11(9), pii: E1219. Italy (NOD.SCID)
    479. Ghosh, S.,et al., Front Oncol, 9, 17. Israel (NOD.SCID)
    480. Kalli, M., et al. (2019). Front Oncol, 9,32. Cyprus (NOD.SCID)
    481. Ron, A., et al. (2019). Cancer Res, 79(18), 4767-4775. Germany (NOD.SCID)
    482. Santoro, A., et al. (2019). Cell Rep, 26(3), 624-638.e8. Italy (NOD.SCID)
    483. Schrama, D., et al. (2019). Int J Cancer, 145(4), 1020-1032. Germany (NOD.SCID)
    484. Stafman, L.L., et al. Sci Rep, 9(1), 13259. North America (NOD.SCID)
    485. Terrasi, A., et al. (2019). EBioMedicine, 41, 214-224. Italy (NOD.SCID)
    486. Woosley, A.N., et al.Oncogene, 38(20), 3794-3811 North America (NOD.SCID)
    487. Wu, J. et al. (2019). Nature, 572(7769), 402-406. North America (NOD.SCID)
    488. Aasen, S.N., et al. (2019). Int J Mol Sci, 20(17). Norway (NOD.SCID)
    489. Amodio, N., et al., (2019). Cancers (Basel), 18, 11(2). pii: E236. Italy (NOD.SCID)
    490. Badarni, M., et al. (2019). JCI Insight, 5. pii: 125341. Israel (NOD.SCID)
    491. Benguigui M, et al. (2019). Sci Rep, 9(1), 12613. Israel (NOD.SCID)
    492. Falah, M., et al. (2019). Int J Mol Sci, 20(19). Israel (NOD.SCID)
    493. Feng, Y., etal. (2019). J Exp Clin Cancer Res, 38(1), 54. China (NOD.SCID)
    494. Hammer, S., et al. (2020) Clin Cancer Res, 26(8),1985-1996. Germany (NOD.SCID)
    495. Hoogi, S., et al. (2019). J Immunother Cancer, 7(1), 243. Israel (NOD.SCID)
    496. Krishnamoorthy, G.P., et al. (2019). Cancer Discov, 9(2), 264-281. North America (NOD.SCID)
    497. La Rocca, F., et al. (2017). Cell Oncol (Dordr), 40(5), 483-496. Italy (NOD.SCID)
    498. Otto, M., et al. (2019). Clin Oral Investig, 23(10), 3767-3775. Germany (NOD.SCID)
    499. Punzi, S., et al. (2019). Breast Cancer Res, 21(1), 123. Italy (NOD.SCID)
    500. Sharma, S. et al., (2019). EBioMedicine, 44, 194-208. North America (NOD.SCID)
    501. Fusciello, M., etal. (2019). Nat Commun, 10(1), 5747. Canada (athymic nude mice)
    502. Neiveyans, M., et al. (2019). Mabs, 11(3), 593-605. France (athymic nude mice)
    503. Ryu, J.S., et al. (2019). Cancers (Basel), 11(4), pii: E574. Korea (athymic nude mice)
    504. Sayyad M.R., et al. (2019). Breast Cancer Res Treat, 178(1), 35-49. North America (athymic nude mice)
    505. Schweppe, R.E., et al. (2019). Mol Cancer Res, 17(5), 1036-1048. North America (athymic nude mice)
    506. Stafman, L.L., et al. (2019). Transl Oncol, 12(2), 200-208. North America (athymic nude mice)
    507. Akla B., et al. (2020). Mol Cancer Ther, 19(1), 168-177. France (athymic nude mice)
    508. Assimon, V.A., et al. (2019). ACS Chem Biol, 14(2), 236-244. North America (athymic nude mice)
    509. Belli, V., et al. (2019). Exp Clin Cancer Res, 38(1), 236. Italy (athymic nude mice)
    510. Capasso, A., et al. (2019). Mol Cancer Ther,18(11), 1916-1925. North America (athymic nude mice)
    511. Casagrande N., et al. (2019). Haematologica, 104(3), 564-575. Italy (athymic nude mice)
    512. Duo, L., et al. (2019). Nat Commun, 10(1), 5051. China (athymic nude mice)
    513. Eskra, J.N., et al. (2019). Prostate, 79(2), 223-233.North America (athymic nude mice)
    514. Fok, J.H.L., et al. (2019). Nat Commun, 10(1), 5065. UK (athymic nude mice)
    515. Formisano, L., et al. (2019). Nat Commun, 10(1), 1373. North America (athymic nude mice)
    516. Hain, B.A., et al. (2019). JCSM Rapid Commun, 2(1), pii: e00075. North America (athymic nude mice)
    517. Hegde, G.V., et al. (2019). Elife, 8, pii: e46551. North America (athymic nude mice)
    518. Kietzman, W.B., et al. (2019). Mol Cancer Ther, 18(12), 2220-2232. North America (athymic nude mice)
    519. Liu, P., et al. (2019). Nat Commun, 10(1), 1486. France (athymic nude mice)
    520. Maaland, A.F., et al. (2019). Eur J Nucl Med Mol Imaging, 46(11), 2311-2321. Norway (athymic nude mice)
    521. Moon, H.H. et al. (2019). Endocrinology, 160(8), 1786-1796. North America (athymic nude mice)
    522. Nguyen, T., et al. (2019). Cell Rep, 27(2), 491-501.e6. North America (athymic nude mice)
    523. Rello-Varona, S., et al. (2019). Sci Rep, 9(1), 3816. Spain (athymic nude mice)
    524. Williams, A.P., et al. (2019). Transl Oncol, 12(10), 1364-1374. North America (athymic nude mice)
    525. Wu, J., et al. (2019). Nature, 572(7769), 402-406. North America (athymic nude mice)
    526. Yang, H., et al. (2019). Clin Cancer Res, 25(18), 5702-5716. North America (athymic nude mice)
    527. Yang, L., et al. (2019). Sci Transl Med, 11(476). North America (athymic nude mice)
    528. Chang, Y.C., et al. (2017). Sci Rep, 7(1), 9746. North America (RAG2 KO(SD))
    529. Fisher, C., et al. (2019). J Clin Med, 8(12), pii: E2214. North American (RAG2 KO(SD))
    530. Chen, Z.H., et al. (2019). J Exp Clin Cancer Res, 14;38(1), 196. China (B-NDG)
    531. Chen, Z., et al. (2019). EBioMedicine, 47, 208-220. China (B-NDG)
    532. Dai, K, et al. (2018). Eur J Immunol, 48(4), 683-695. China (B-NDG)
    533. Li, Y., et al. (2018). J Exp Clin Cancer Res, 37(1), 276. China (B-NDG)
    534. Sun, B., et al. (2019). Cancer Immunol Res, 7(11), 1813-1823. China (B-NDG)
    535. Wang, J., et al. (2020). Thorac Cancer. China (B-NDG)
    536. Wang, Q., et al. (2018). Clin Cancer Res, 24(4), 950-962. China (B-NDG)
    537. Xia, J., et al. (2020). Mol Oncol, 14(4), 763-778. China (B-NDG)
    538. Xiao, X., et al. (2017). Cell Death Dis, 8(9), e3050. China (B-NDG)
    539. Ao, X., et al. (2019). J Immunother, 42(8), 284-296. China (B-NDG)
    540. Chen, H.D., et al. (2020). Int J Biol Sci, 16(7), 1207-1217. China (B-NDG)
    541. Gao , X., et al. (2019). Clin Cancer Res, 25(4), 1291-1301. China (B-NDG)
    542. Gong, J., et al. (2020). Artif Cells Nanomed Biotechnol, 48(1), 408-414. China (B-NDG)
    543. Chen, R., et al. (2020). Cancer Lett. 469, 162-172. China (B-NDG)
    544. Huang W., et al. (2020). Cell Death Differ, 27(5), 1709-1727. China (B-NDG)
    545. Lei, H., et al. (2019). Cancer Invest, 37(6), 242-252. China (B-NDG)
    546. Sun, Y., et al. (2019). EBioMedicine, 43, 171-179. China (B-NDG)
    547. Wang, D., et al. (2018). J Cell Mol Med, 22(12), 6202-6212. China (B-NDG)
    548. Wu, R., et al. (2019). Pharmacol Res, 150, 104454. China (B-NDG)
    549. Xiao, H., et al. (2019). Cancer Cell Int, 19, 218. China (B-NDG)
    550. Yang, D. , et al. (2019). J Immunother Cancer, 7(1), 171. China (B-NDG)
    551. Zhan, Y., et al. (2020). Mol Cancer, 19(1), 25. China (B-NDG)
    552. Zhang, P., et al. (2020). J Biomed Sci, 27(1), 30. China (B-NDG)
    553. Zhao, B., et al. (2019). Theranostics, 9(7), 1837-1850. China (B-NDG)
    Many factors can influence your selection of an appropriate research model. These published studies are identified to assist you in your selection. Envigo does not guarantee model performance in research studies.
    The cell line abbreviation “(PDX)” is utilized as a generic naming convention of a “Patient-derived Xenograft” in absence of a formal name by the researcher(s).

     

    Learn more

    Brad Gien

    Meet Brad
    Gien

    Global Head of Surgery

    View profile View profile  
    Sheryl Wildt

    Meet Sheryl
    Wildt

    Scientist

    View profile View profile